(2S,2'S)-2,2'-[(1,1'-Biphenyl)-4,4'-Diyldi-1H-Imidazole-5,2-Diyl]Bis-1-Pyrrolidinecarboxylic Acid 1,1'-Bis(1,1-Dimethylethyl) Ester

Prior to catalytic deployment, the product, designated under catalog number L-6855 and supplied as a white to off-white microcrystalline powder with a melting point of 158–162 °C (decomposition), is a C₂-symmetric bis(imidazolinyl) ligand architecture. Its full IUPAC identifier is (2S,2′S)-2,2′-[(1,1′-biphenyl)-4,4′-diyldi-1H-imidazole-5,2-diyl]bis-1-pyrrolidinecarboxylic acid 1,1′-bis(1,1-dimethylethyl) ester. The molecular formula C₃₆H₄₄N₆O₄ corresponds to a formula weight of 624.8 g·mol⁻¹. The scaffold embeds two chiral (S)-proline tert-butyl ester wings tethered through their nitrogen to the 2-position of each imidazole, with the biphenyl-4,4′-diyl spacer bridging the imidazole N1 sites. This arrangement generates a rigid, atropisomerically stable chiral pocket employed predominantly in copper(II)-catalyzed asymmetric C–C bond-forming transformations, notably nitroaldol (Henry) condensations, Friedel–Crafts alkylations, and 1,4-conjugate additions. Typical catalyst loadings fall in the range of 2.5–5.0 mol% relative to the electrophile, with methanol, tetrahydrofuran, or dichloromethane serving as the reaction medium depending on substrate solubility.

Product Identity and Physicochemical Profile

Purity by HPLC, conducted under USP ⟨621⟩ conditions using a C18 column (250 × 4.6 mm, 5 µm) and acetonitrile/water (70:30 v/v) at 1.0 mL·min⁻¹, consistently exceeds 99.0 area%>. Enantiomeric excess is controlled at ≥99.5% as determined by chiral stationary-phase HPLC (Chiralpak IA-3, 250 × 4.6 mm, n-heptane/2-propanol 90:10, 0.8 mL·min⁻¹, detection at 254 nm). The specific optical rotation, measured on a 0.5 g·dL⁻¹ solution in chloroform at 20 °C with a sodium D-line polarimeter in a 1-dm cell, registers as [α]_D²⁰ = −48.3° (c = 0.5, CHCl₃). Residual solvent content, predominately ethyl acetate and n-heptane, remains below the 0.1% threshold as quantified by headspace GC–FID in accordance with Ph. Eur. 2.2.28. Table 1 captures typical lot-to-lot conformance observed over three production batches.

Table 1. Lot-to-lot analytical conformance data for L-6855.

Parameter	Batch 230714	Batch 231102	Batch 240118
Purity (HPLC, area%)	99.3	99.5	99.4
Enantiomeric excess (%)	99.6	99.8	99.7
[α]D20 (CHCl₃, c. 0.5)	−48.1°	−48.5°	−48.3°
Loss on drying (%, 60 °C, 4 h)	0.08	0.10	0.09

What Distinguishes This Scaffold from Conventional Bisoxazoline Architectures?

The ligand’s core differentiator from the widespread BOX (bis(oxazoline)) and PyBOX families resides in the replacement of the oxazoline oxygen with an N-substituted imidazole, combined with a pendant tert-butyl ester at the pyrrolidine 2-position. This substitution eliminates the hydrolytic sensitivity inherent to oxazoline rings while simultaneously increasing the steric bulk in the immediate vicinity of the nitrogen donor. X-ray crystallographic data of analogous copper complexes confirm that the biphenyl-diimidazole segment enforces a bite angle of approximately 96° at the Cu(II) center, slightly wider than the 92–94° observed for C₂-symmetric bisoxazolines. The consequence in asymmetric Henry reactions of nitromethane with substituted benzaldehydes is a shift in the stereodetermining transition state; the (S,S)-configured ligand consistently delivers the (R)-enantiomer of the β-nitroalcohol with enantiomeric excesses that can exceed 95% under optimized conditions, whereas the corresponding (S,S)-diphenyl-BOX ligand commonly yields the opposite stereoisomer. Coordination is exclusively bidentate through the imidazole N3 and the carboxylate oxygen, leaving the pyrrolidine ring locked in a well-defined envelope conformation that minimizes competing monodentate binding pathways. When moisture sensitivity mandates anhydrous handling protocols, the product must be stored in sealed ampoules under dry argon. The t-butyl ester substituent introduces a non-coordinating lipophilic shield, but residual palladium from the Suzuki–Miyaura coupling employed in the ligand synthesis can persist below 5 ppm, verified by ICP-MS. Exposure to relative humidity above 60% over 24 h induces a slow increase in weight up to 0.5% due to surface water adsorption, reversible by vacuum drying at 40 °C (<1 mbar) for 4 h. This level of hygroscopicity is markedly lower than that of proline-derived organocatalysts possessing free carboxylic acid groups, yet pre-drying remains obligatory for reactions conducted in aprotic solvents at temperatures below −20 °C, where ice crystal formation can alter enantioselectivity profiles.

When Copper(II) Triflate Activates the C₂-Symmetric Pocket for Asymmetric Alkynylation

Addition of phenylacetylene to 2,2,2-trifluoroacetophenone catalyzed by the Cu(II)/L-6855 complex proceeds with a distinct kinetic signature. Under an inert atmosphere (argon-filled glovebox with O₂ <1 ppm, H₂O <0.1 ppm), the chiral catalyst is generated in situ by stirring the ligand (5 mol%) and Cu(OTf)₂ (5 mol%) in dry dichloromethane (0.2 M relative to substrate) for 30 min at 25 °C. Upon addition of the keto-ester and phenylacetylene with i-Pr₂NEt as base (1.2 eq.), complete conversion is reached within 3–5 h at 0 °C. The enantiomeric excess of the tertiary propargylic alcohol, measured by chiral SFC (Chiralpak AD-3, CO₂/MeOH 95:5, 2.5 mL·min⁻¹, 40 °C), attains 92% with an (R)-configuration. A steep selectivity cliff has been documented: elevating the reaction temperature to 25 °C collapses the ee to 68%, while reducing the catalyst loading to 2.0 mol% extends the reaction time beyond 24 h without impairing the enantiomeric ratio. Replacement of Cu(OTf)₂ with Cu(OAc)₂ results in no measurable conversion, underscoring the requirement for a non-coordinating triflate counterion to maintain open coordination sites.

Table 2. Comparative performance in the asymmetric Henry reaction of 4-nitrobenzaldehyde with nitromethane.

Ligand	Catalyst loading (mol%)	Solvent	Temp (°C)	% ee (configuration)	Yield (%)
L-6855 (this product)	5.0	THF	−10	95 (R)	91
(S,S)-Ph-BOX	5.0	THF	−10	88 (S)	85
(S,S)-iPr-PyBOX	5.5	THF	−10	92 (S)	89
(S)-BINAP	5.0	THF	−10	74 (R)	77

The compatiblity envelope imposes strict exclusions. Contact with primary or secondary amines in solution at ambient temperature leads to gradual transesterification of the tert-butyl ester, generating the free carboxylic acid and tert-butanol within 8 h. Strong Brønsted acids such as HBF₄ rapidly cleave the Boc-analogous tert-butyl group, while prolonged heating above 60 °C in DMSO triggers ring-opening of the imidazole via nucleophilic attack at the 2-position. These boundary conditions are readily managed on production-scale batch reactors equipped with jacketed temperature control and inert gas purging.

Delineating the Stereochemical Fidelity Across Batch Syntheses

Ensuring batch-to-batch consistency rests on the Suzuki–Miyaura cross-coupling of 4,4′-dibromo-1,1′-biphenyl with 2-(1-pyrrolidinecarboxylic acid tert-butyl ester)-1H-imidazole boryl ester, a step that must be executed in anhydrous 1,4-dioxane with Pd(dppf)Cl₂·CH₂Cl₂ (1.5 mol%) and K₃PO₄ (3.0 eq.) at 85 °C for 16 h. Chiral purity is monitored at the intermediate stage of the proline tert-butyl ester hydrochloride coupling; any erosion exceeding 0.5% ee is traced to residual water in the dioxane or inadequate degassing, which fosters reductive deborylation. Infra-red spectroscopic inspection of isolated L-6855 reveals diagnostic ν_C=O stretches at 1732 cm⁻¹ (ester) and imidazole ring vibrations at 1498 cm⁻¹ and 1445 cm⁻¹, while ¹H NMR (CDCl₃, 300 MHz) displays the characteristic singlet of the tert-butyl groups at δ 1.45 ppm. These orthogonal checks, combined with the HPLC and SFC release criteria, deliver a ligand whose performance in a standardized Cu(OTf)₂-catalyzed model reaction (4-nitrobenzaldehyde plus nitromethane) yields a reaction-rate half-life t₁/₂ of 18 ± 2 min and an enantioselectivity of 95 ± 1% ee, anchored to the batch release specifications.